BRIDGEBIO PHARMA INC's ticker is BBIO and the CUSIP is 10806X102. A total of 182 filers reported holding BRIDGEBIO PHARMA INC in Q1 2022. The put-call ratio across all filers is 0.50 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $2,606,000 | -38.4% | 256,756 | +1.2% | 0.02% | -37.0% |
| Q4 2021 | $4,232,000 | +22.5% | 253,726 | +244.1% | 0.03% | +17.4% |
| Q3 2021 | $3,456,000 | +22.4% | 73,734 | +59.2% | 0.02% | +21.1% |
| Q2 2021 | $2,823,000 | +1.3% | 46,309 | +2.3% | 0.02% | 0.0% |
| Q1 2021 | $2,787,000 | -51.4% | 45,248 | -43.9% | 0.02% | -54.8% |
| Q4 2020 | $5,736,000 | +63.4% | 80,670 | -13.8% | 0.04% | +40.0% |
| Q3 2020 | $3,510,000 | – | 93,542 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 3,835,722 | $82,353,000 | 42.93% |
| Kohlberg Kravis Roberts & Co. L.P. | 36,900,661 | $792,257,000 | 4.46% |
| Perceptive Advisors | 6,706,268 | $143,983,000 | 3.88% |
| Cormorant Asset Management, LP | 2,617,566 | $56,199,000 | 3.42% |
| VIKING GLOBAL INVESTORS LP | 26,620,991 | $571,553,000 | 2.98% |
| SC US (TTGP), LTD. | 2,544,738 | $54,636,000 | 2.42% |
| HHLR ADVISORS, LTD. | 4,388,690 | $94,225,000 | 1.30% |
| Fernwood Investment Management, LLC | 95,200 | $2,044,000 | 1.01% |
| AMERICAN INTERNATIONAL GROUP, INC. | 6,746,511 | $144,847,000 | 0.58% |
| Ratan Capital Management LP | 46,548 | $999,000 | 0.53% |